Analyzing BioXcel Therapeutics Inc (BTAI)’s Gross, Operating, Pretax, and Net Margins
BioXcel Therapeutics Inc [BTAI] stock is trading at $3.37, up 22.99%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BTAI shares have gain 56.02% over the last week, with a monthly amount drifted -29.53%, and not seem to be holding up well over […]
BioXcel Therapeutics Inc (BTAI) Stock Up 73.61%: Latest Performance Analysis
Currently, BioXcel Therapeutics Inc [BTAI] is trading at $3.75, up 73.61%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The BTAI shares have gain 90.36% over the last week, with a monthly amount drifted -27.42%, and not seem to be holding up well […]
What to know about BioXcel Therapeutics Inc (BTAI)’s sales and margins
BioXcel Therapeutics Inc [BTAI] stock prices are up 7.53% to $0.37 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The BTAI shares have gain 6.28% over the last week, with a monthly amount glided 5.54%, and seem to be holding […]
BioXcel Therapeutics Inc (BTAI) Stock Up 4.48%: Latest Performance Analysis
BioXcel Therapeutics Inc [BTAI] stock is trading at $0.38, up 4.48%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The BTAI shares have gain 9.61% over the last week, with a monthly amount glided 20.42%, and seem to be holding up well […]
